Results 71 to 80 of about 1,543 (142)

Risk Factors of Blood Culture Positivity and Mortality in Bloodstream Infections: A Population‐Based Study of Patients With B‐Cell Malignancies

open access: yesEuropean Journal of Haematology, Volume 117, Issue 4, Page 1061-1071, October 2026.
ABSTRACT Background Bloodstream infections remain a major cause of mortality among cancer patients. Pathogen surveillance and risk stratification tools are key to improved management. This study describes trends in causative pathogens and explores risk factors for positive blood cultures (PBCs) and post‐infection mortality in cancer patients.
Mathias Holmsgaard Eskesen   +7 more
wiley   +1 more source

The effect of silver nanoparticles on Gram-negative bacilli Resistant to Extended-Spectrum Β-Lactamase Enzymes

open access: yesMedical Laboratory Journal, 2011
: Background and objectives: Antibiotic resistant to Antimicrobial agents is one of the most important concern in hospitals, which can lead to increased costs, treatment fails and mortality rates. The aim of this study was identification of Gram-negative
Doudi M, Naghsh N, Heiedarpour A
doaj  

Living with ESBLs [PDF]

open access: yesClinical Microbiology and Infection, 2007
Cornaglia, G.   +2 more
openaire   +1 more source

Comparison of virulence factors between ESBL and non-ESBL producing Klebsiella pneumoniae isolates

open access: yesIranian Journal of Microbiology
Background and Objectives: Klebsiella pneumoniae is an opportunistic pathogen responsible for causing nosocomial and community-acquired infections. Its pathogenicity is associated with a variety of virulence factors and antibiotic resistance. The aim of the present study was to compare virulence attributes between ESBL and non-ESBL producing isolates.
Hamed Hatami Mirbag   +3 more
openaire   +3 more sources

Risk factors for extended-spectrum b-lactamases-producing Escherichia coli urinary tract infections in a tertiary hospital

open access: yesSalud Pública de México, 2015
Objective. To assess the risks factors for urinary tract infections (UTIs) caused by Extended-Spectrum Beta-Lactamases (ESBLs)-producing E. coli and the molecular characterization of ESBLs. Materials and methods.
María Dolores Alcántar-Curiel   +7 more
doaj   +1 more source

Effectiveness of Pre-Transplant Screening for High-Priority Multidrug-Resistant Pathogens on Pre-Engraftment Infections After Hematopoietic Stem Cell Transplantation

open access: yesInfection and Drug Resistance
Noha A Kamel,1 Mahmoud S Abdalla,2 Amer Al Ali,3 Mohammad Y Alshahrani,4 Khaled M Aboshanab,5,6 Mervat I El Borhamy1,7 1Department of Microbiology, Faculty of Pharmacy, Misr International University (MIU), Cairo, Egypt; 2Hematology and Bone Marrow ...
Kamel NA   +5 more
doaj  

Relationship Between Drug Resistance Characteristics and Biofilm Formation in Klebsiella Pneumoniae Strains

open access: yesInfection and Drug Resistance, 2023
Binzhi Dan,* Heping Dai,* Dangui Zhou, Hongfang Tong, Mei Zhu Department of Clinical Laboratory, the Affiliated Chaohu Hospital of Anhui Medical University, Chaohu, Anhui, People’s Republic of China*These authors contributed equally to this ...
Dan B, Dai H, Zhou D, Tong H, Zhu M
doaj  

Extended-Spectrum Beta-Lactamases

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology, 2006
The definition of extended-spectrum beta-lactamases (ESBLs) has expanded rapidly, in terms of both the number and the variety of enzymes. Bacteria bearing plasmidic ESBLs are spreading widely throughout the world.
Kevin R Forward
doaj   +1 more source

Targeted mechanisms and novel therapeutic strategies against extended-spectrum beta-lactamases: From precise detection to intelligent management of bacterial resistance

open access: yesJournal of Current Biomedical Reports
Extended-spectrum beta-lactamases (ESBLs) are enzymes that resist beta-lactam antibiotics, including penicillins, cephalosporins, and carbapenems, and are produced by a variety of bacteria, including Escherichia coli and Klebsiella pneumoniae.
Abolfazl Jafari-Sales   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy